Skip to content
  • Research

Latest Research

Blue abstract image of water droplets and particles under a microscope.

Industry Report: Stem Cell Therapies – Regulatory Validation Meets Near-Term Catalysts (ASX:MSB, ASX:CYP, ASX:NSB)

Jun 10, 2026
(ASX:ILA) Island Pharmaceuticals – Regulatory Alignment and Strategic Partnerships Accelerate Galidesivir Toward Animal Rule Approval

(ASX:ILA) Island Pharmaceuticals – Regulatory Alignment and Strategic Partnerships Accelerate Galidesivir Toward Animal Rule Approval

Mar 4, 2026
Entropy Logo

(ASX:ENP) Entropy Neurodynamics – Patented Psychedelic Treatment Through Precision IV Dosing

Feb 17, 2026
(ASX:ILA) Island Pharmaceuticals – FDA Confirms Animal Rule Pathway for Galidesivir

(ASX:ILA) Island Pharmaceuticals – FDA Confirms Animal Rule Pathway for Galidesivir

Nov 17, 2025
(ASX:ILA) Island Pharmaceuticals – FDA Meeting Granted

(ASX:ILA) Island Pharmaceuticals – FDA Meeting Granted

Oct 9, 2025
(ASX:ILA) Island Pharmaceuticals – Two Shots at a Billion-Dollar Prize in Antivirals

(ASX:ILA) Island Pharmaceuticals – Two Shots at a Billion-Dollar Prize in Antivirals

Aug 26, 2025

© 2026 Prenzler Group - All Rights Reserved. 

Prenzler Group Pty Ltd (ABN 77 621 100 730) is a corporate Authorised Representative (1257636) of BR Securities Australia Pty Ltd (ABN 92 168 734 530), the holder of Australian Financial Services Licence number 456663. The information contained in this website is only intended for the use of those persons who satisfy the Wholesale definition, pursuant to Section 761G and Section 761GA of the Corporations Act 2001 (Cth) (“the Act”). Persons accessing this information should consider whether they are wholesale clients in accordance with the Act before relying on any information contained. Any advice provided is general in nature.

Prenzler Group FSG

Privacy Policy

Disclaimers